Skip to main content
. 2014 Oct 13;7:1875–1881. doi: 10.2147/OTT.S66525

Table 2.

Efficacy of docetaxel-platinum and docetaxel single-agent group

Docetaxel-platinum group (n=44) Docetaxel group (n=41) P-value
Complete response 0 0
Partial response 13 8
Stable disease 14 13
Progressive disease 17 20
Response rate 29.5% 19.5% 0.28
Disease control rate 61.4% 51.2% 0.35
Median progression-free survival 3.6 months 3.2 months 0.38
Median overall survival 5.7 months 5.2 months 0.64